Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-04-23
2000-03-21
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546257, 546286, 546290, 546300, 514333, 514277, 514344, A01N 4340, C07D21130, C07D21178, C07D21172, C07D21362
Patent
active
060403195
ABSTRACT:
The invention encompasses a process for making compounds of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1##
REFERENCES:
patent: 5861419 (1999-01-01), Dube et al.
Die Pharmazie,vol. 51 , K.Gorlitzer et al , Darstellung und Reaktionen von 3'-aza-nifedipin. pp. 207-212, Apr. 19, 1996.
Corley Edward G.
Davies Ian W.
Larsen Robert D.
Pye Philip J.
Rossen Kai
Billups Richard C.
Desai Rita
Kight John
Merck & Co. , Inc.
Rose David L.
LandOfFree
Process for synthesizing COX-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for synthesizing COX-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for synthesizing COX-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-730598